These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11959334)

  • 1. Fatty acid composition of low-density lipoprotein in renal transplant recipients treated with cyclosporine.
    Cofan F; Zambon D; Laguna JC; Ros E; Casals E; Cofan M; Campistol JM; Oppenheimer F
    Transplant Proc; 2002 Feb; 34(1):374-6. PubMed ID: 11959334
    [No Abstract]   [Full Text] [Related]  

  • 2. Fatty acid composition in low-density lipoproteins from renal transplant recipients.
    Cofan F; Zambon D; Rodriguez C; Laguna JC; Vazquez M; Casals E; Torregrosa J; Ros E; Oppenheimer F
    Transplant Proc; 1999 Sep; 31(6):2330-2. PubMed ID: 10500603
    [No Abstract]   [Full Text] [Related]  

  • 3. Low-density lipoprotein oxidizability and the alteration of its fatty acid content in renal transplant recipients treated with cyclosporine/tacrolimus.
    Bakar F; Keven K; Dogru B; Aktan F; Erturk S; Tuzuner A; Erbay B; Nebioglu S
    Transplant Proc; 2009 Jun; 41(5):1630-3. PubMed ID: 19545695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidation of low-density lipoproteins in renal transplant recipients.
    Cofan F; Zambon D; Rodriguez C; Laguna JC; Vazquez M; Casals E; Torregrosa J; Ros E; Oppenheimer F
    Transplant Proc; 1999 Sep; 31(6):2333-4. PubMed ID: 10500604
    [No Abstract]   [Full Text] [Related]  

  • 5. Low-density lipoprotein composition and oxidation are not influenced by calcineurin inhibitors in renal transplant patients.
    Morena M; Vela C; Garrigue V; Catanzano J; Descomps B; Cristol JP; Mourad G
    Transplant Proc; 2000 Dec; 32(8):2785-6. PubMed ID: 11134805
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma and low-density lipoprotein lipid peroxidation in cyclosporine A-treated children after liver transplant.
    Granot E; Shemesh P; Rivkin L; Kohen R
    Transplant Proc; 1998 Dec; 30(8):4057-9. PubMed ID: 9865293
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of calcineurin inhibitors on low-density lipoprotein oxidation.
    Cofan F; Cofan M; Campos B; Guerra R; Campistol JM; Oppenheimer F
    Transplant Proc; 2005 Nov; 37(9):3791-3. PubMed ID: 16386540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidizability of low-density lipoproteins from Neoral and tacrolimus-treated renal transplant patients.
    Varghese Z; Fernando RL; Turakhia G; Psimenou E; Brunton C; Fernando ON; Davenport A; Burns A; Sweny P; Powis SH; Moorhead JF
    Transplant Proc; 1998 Aug; 30(5):2043-6. PubMed ID: 9723384
    [No Abstract]   [Full Text] [Related]  

  • 9. Disturbances in serum lipids and in their fatty acid composition following acute myocardial infarction.
    Kirkeby K
    Acta Med Scand; 1972 Dec; 192(6):523-8. PubMed ID: 4344950
    [No Abstract]   [Full Text] [Related]  

  • 10. Oxidation of low-density lipoproteins in renal transplant recipients treated with tacrolimus.
    Cofan F; Zambon D; Laguna JC; Ros E; Casals E; Cofan M; Campistol JM; Oppenheimer F
    Transplant Proc; 2002 Feb; 34(1):377-8. PubMed ID: 11959335
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclosporin A does not increase the oxidative susceptibility of low density lipoprotein in vitro.
    Devaraj S; Li DJ; Vazquez M; Jialal I
    Free Radic Biol Med; 1999 Apr; 26(7-8):1064-8. PubMed ID: 10232852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperhomocysteinemia in renal transplant recipients with cyclosporine.
    Kim SI; Yoo TH; Song HY; Hwang JH; Lee HY; Han DS; Moon JI; Kim YS; Park KI; Paeng KJ; Choi KH
    Transplant Proc; 2000 Nov; 32(7):1878-9. PubMed ID: 11119981
    [No Abstract]   [Full Text] [Related]  

  • 13. Missing impact of cyclosporine on osteoporosis in renal transplant recipients.
    Grotz W; Mundinger A; Gugel B; Exner V; Reichelt A; Schollmeyer P
    Transplant Proc; 1994 Oct; 26(5):2652-3. PubMed ID: 7940828
    [No Abstract]   [Full Text] [Related]  

  • 14. Small dense low-density lipoprotein in renal transplant recipients: a potential target for prevention of cardiovascular complications?
    Badiou S; Garrigue V; Dupuy AM; Chong G; Cristol JP; Mourad G
    Transplant Proc; 2006 Sep; 38(7):2314-6. PubMed ID: 16980076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirolimus changes lipid concentrations and lipoprotein metabolism in kidney transplant recipients.
    Morrisett JD; Abdel-Fattah G; Kahan BD
    Transplant Proc; 2003 May; 35(3 Suppl):143S-150S. PubMed ID: 12742487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperlipidemia in children: the role of uremia, steroids and cyclosporine therapy.
    Singh A; Tejani A
    Nephron; 1996; 74(3):529-35. PubMed ID: 8938676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of glucocorticoid-free immunosuppressive protocol on serum lipids in renal transplant patients.
    Nowacka-Cieciura E; Soluch L; Cieciura T; Lewandowska D; Durlik M; Shaibani B; Serafinowicz A; Szmidt J; Rowiński W; Lao M
    Transplant Proc; 2000 Sep; 32(6):1339-43. PubMed ID: 10995973
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of fluvastatin on hyperlipidemia after renal transplantation: influence of steroid therapy.
    Austen JL; Shifrin FA; Bartucci MR; Knauss TC; Schulak JA; Hricik DE
    Ann Pharmacother; 1996 Dec; 30(12):1386-9. PubMed ID: 8968448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase in hydroxy fatty acids in human low density lipoproteins with age.
    Jira W; Spiteller G; Schramm A
    Chem Phys Lipids; 1996 Dec; 84(2):165-73. PubMed ID: 9022221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of blood pressure circadian rhythm in renal transplant recipients taking cyclosporine.
    Keitel E; Fuchs FD; Costa CA; Bittar AE; Goldani JC; Garcia VD
    Transplant Proc; 1997; 29(1-2):222. PubMed ID: 9122970
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.